Completed NA INTERVENTIONAL 2-arm NCT02449733

Comprehensive HIV Prevention Package for MSM in Port Elizabeth

Sponsor: Emory University

Conditions HIV

Interventions Condom choices Condom-compatible lubricant choices Couples HIV counseling and testing (CVCT) Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) HIV Testing Linkage to care Post-exposure prophylaxis (PEP) Risk-reduction counseling

Updated 8 times since 2017 Last updated: Jul 4, 2017 Started: May 31, 2015 Primary completion: Oct 31, 2016 Completion: Mar 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02449733, this NA trial focuses on HIV and remains completed. Sponsored by Emory University, it has been updated 8 times since 2015, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Aug 2017 — Jun 2018 [monthly]

Completed NA

Status: Active Not Recruiting → Completed

▶ Show 3 earlier versions

May 2017 — Aug 2017 [monthly]

Active Not Recruiting NA
Feb 2017 — May 2017 [monthly]

Active Not Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting NA

First recorded

May 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Emory University

Data source: Emory University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Port Elizabeth, South Africa